180 related articles for article (PubMed ID: 36344069)
1. Update on Innate and Adaptive Immunity in Cystic Fibrosis.
Bruscia EM; Bonfield TL
Clin Chest Med; 2022 Dec; 43(4):603-615. PubMed ID: 36344069
[TBL] [Abstract][Full Text] [Related]
2. Cystic Fibrosis Lung Immunity: The Role of the Macrophage.
Bruscia EM; Bonfield TL
J Innate Immun; 2016; 8(6):550-563. PubMed ID: 27336915
[TBL] [Abstract][Full Text] [Related]
3. Innate and Adaptive Immunity in Cystic Fibrosis.
Bruscia EM; Bonfield TL
Clin Chest Med; 2016 Mar; 37(1):17-29. PubMed ID: 26857765
[TBL] [Abstract][Full Text] [Related]
4. Defective innate immunity and hyperinflammation in newborn cystic fibrosis transmembrane conductance regulator-knockout ferret lungs.
Keiser NW; Birket SE; Evans IA; Tyler SR; Crooke AK; Sun X; Zhou W; Nellis JR; Stroebele EK; Chu KK; Tearney GJ; Stevens MJ; Harris JK; Rowe SM; Engelhardt JF
Am J Respir Cell Mol Biol; 2015 Jun; 52(6):683-94. PubMed ID: 25317669
[TBL] [Abstract][Full Text] [Related]
5. Lung Inflammatory Genes in Cystic Fibrosis and Their Relevance to Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapies.
Carbone A; Vitullo P; Di Gioia S; Conese M
Genes (Basel); 2023 Oct; 14(10):. PubMed ID: 37895314
[TBL] [Abstract][Full Text] [Related]
6. Anti-Inflammatory Influences of Cystic Fibrosis Transmembrane Conductance Regulator Drugs on Lung Inflammation in Cystic Fibrosis.
Harwood KH; McQuade RM; Jarnicki A; Schneider-Futschik EK
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299226
[TBL] [Abstract][Full Text] [Related]
7. Mucosal Immunity in Cystic Fibrosis.
Bojanowski CM; Lu S; Kolls JK
J Immunol; 2021 Dec; 207(12):2901-2912. PubMed ID: 35802761
[TBL] [Abstract][Full Text] [Related]
8. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by
Marteyn BS; Burgel PR; Meijer L; Witko-Sarsat V
Front Cell Infect Microbiol; 2017; 7():243. PubMed ID: 28713772
[TBL] [Abstract][Full Text] [Related]
9. The NF-kappaB signaling in cystic fibrosis lung disease: pathophysiology and therapeutic potential.
Bodas M; Vij N
Discov Med; 2010 Apr; 9(47):346-56. PubMed ID: 20423679
[TBL] [Abstract][Full Text] [Related]
10. Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have differential effects on cystic fibrosis macrophage function.
Zhang S; Shrestha CL; Kopp BT
Sci Rep; 2018 Nov; 8(1):17066. PubMed ID: 30459435
[TBL] [Abstract][Full Text] [Related]
11. Current concepts of immune dysregulation in cystic fibrosis.
Rieber N; Hector A; Carevic M; Hartl D
Int J Biochem Cell Biol; 2014 Jul; 52():108-12. PubMed ID: 24495876
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of histone-deacetylase activity rescues inflammatory cystic fibrosis lung disease by modulating innate and adaptive immune responses.
Bodas M; Mazur S; Min T; Vij N
Respir Res; 2018 Jan; 19(1):2. PubMed ID: 29301535
[TBL] [Abstract][Full Text] [Related]
13. Emerging Concepts in Defective Macrophage Phagocytosis in Cystic Fibrosis.
Jaganathan D; Bruscia EM; Kopp BT
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887098
[TBL] [Abstract][Full Text] [Related]
14. Aspergillus colonization and antifungal immunity in cystic fibrosis patients.
Warris A; Bercusson A; Armstrong-James D
Med Mycol; 2019 Apr; 57(Supplement_2):S118-S126. PubMed ID: 30816976
[TBL] [Abstract][Full Text] [Related]
15. Dysregulated signalling pathways in innate immune cells with cystic fibrosis mutations.
Lara-Reyna S; Holbrook J; Jarosz-Griffiths HH; Peckham D; McDermott MF
Cell Mol Life Sci; 2020 Nov; 77(22):4485-4503. PubMed ID: 32367193
[TBL] [Abstract][Full Text] [Related]
16. Mouse models of chronic lung infection with Pseudomonas aeruginosa: models for the study of cystic fibrosis.
Stotland PK; Radzioch D; Stevenson MM
Pediatr Pulmonol; 2000 Nov; 30(5):413-24. PubMed ID: 11064433
[TBL] [Abstract][Full Text] [Related]
17. Targeting airway inflammation in cystic fibrosis.
McElvaney OJ; Wade P; Murphy M; Reeves EP; McElvaney NG
Expert Rev Respir Med; 2019 Nov; 13(11):1041-1055. PubMed ID: 31530195
[No Abstract] [Full Text] [Related]
18. Dysfunctional Inflammation in Cystic Fibrosis Airways: From Mechanisms to Novel Therapeutic Approaches.
Ghigo A; Prono G; Riccardi E; De Rose V
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669352
[TBL] [Abstract][Full Text] [Related]
19. Lung phenotype of juvenile and adult cystic fibrosis transmembrane conductance regulator-knockout ferrets.
Sun X; Olivier AK; Liang B; Yi Y; Sui H; Evans TI; Zhang Y; Zhou W; Tyler SR; Fisher JT; Keiser NW; Liu X; Yan Z; Song Y; Goeken JA; Kinyon JM; Fligg D; Wang X; Xie W; Lynch TJ; Kaminsky PM; Stewart ZA; Pope RM; Frana T; Meyerholz DK; Parekh K; Engelhardt JF
Am J Respir Cell Mol Biol; 2014 Mar; 50(3):502-12. PubMed ID: 24074402
[TBL] [Abstract][Full Text] [Related]
20. Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy.
Cantin AM; Hartl D; Konstan MW; Chmiel JF
J Cyst Fibros; 2015 Jul; 14(4):419-30. PubMed ID: 25814049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
